|
||||
|
CA-South San Francisco, Senior Project Manager Portola Pharmaceuticals discovers and develops innovative therapeutics based on targets with established proof of concept that are designed to provide significant advances over current treatments for cardiovascular and inflammatory diseases. In the area of thrombosis, Portola is developing elinogrel, a Phase 3-ready direct-acting, competitive and reversible i.v. and oral P2Y
|
||||
| Senior Project Manager | ||||